imc-001,epcam-targeted car-t
immuneoncia therapeutics,sino bioway
[' epcam', 'imc,001']
dr weijia fang:
the first in human, open label, multicentre trial of epcam targeted car-t cell therapy using imc001 showed a favorable safety profile and reasonable anti-tumor activities at the initial dosage level in patients with cancers of digestive system. #esmo2022
Flagship #OpenAccess medical journal from @BioMedCentral. Publishes research articles & reviews in all areas of research & practice in #medicine & #globalhealth